The introduction of AbbVie’s hepatitis C drugs in 2014 forced Gilead’s hand in the fight for market dominance in hepatitis C.
The Community Network for Em- powerment (CoNE) has kicked off International Testing Week (ITW) 2025 at its office today.The ...
A food handler at a Burlington restaurant has been confirmed to have hepatitis A, and may have exposed customers to the virus ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today reported that it has received approval to Start Phase II Clinical Trial of ...
Enanta Pharmaceuticals recorded a narrower loss as sales rose in its fiscal fourth quarter driven by higher sales of a hepatitis C virus treatment.
Health and Me on MSN
Can Catching The Flu Or COVID-19 Sharply Raise Your Heart Risk?
A major review shows flu and COVID-19 infections can sharply raise short-term risks of heart attacks and strokes, with ...
Researchers have found in the phase II SOLSTICE trial that the investigational combination of tobevibart plus elebsiran ...
Scientists have recently conducted a meta-analysis of over 150 research studies, and determined that infections with viruses ...
The ECDC says the region could still meet its testing targets for HIV, but that it will be harder to improve detection for ...
The Kurdistan Workers' Party (PKK) on Monday said it had withdrawn its fighters from areas in the Zap region, along the ...
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive top-line results from the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback